Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer

Status Active, not recruiting

Clinical Trial Summary

RATIONALE: A low-fat, balanced diet may prevent disease progression in patients with nonmelanomatous skin cancer.

PURPOSE: Randomized phase II trial to study the effectiveness of a low-fat, balanced diet to prevent disease progression in patients with nonmelanomatous skin cancer.

Clinical Trial Description

OBJECTIVES: I. Determine whether intervention with a low-fat balanced diet will prolong the disease-free survival time in patients presenting with nonmelanomatous skin cancer and having a history of not more than two previous skin cancers. II. Assess the effect of this intervention on numbers of tumors during the two year follow-up period. III. Determine the incidence of new skin cancer in the control, nonintervention population.

OUTLINE: This is a randomized study. Patients are randomized into the Dietary Intervention or Nonintervention groups. The control group has initial and follow up assessment of eating habits. The dietary intervention group also has initial and follow up assessment of eating habits that have been changed to reduce fat intake to one-half of the amount in the average American diet with a subsequent increase of carbohydrates to compensate for total caloric intake. Both groups have assessment of clinical status of skin cancer at 4 month intervals for 24 months. Patients are followed for two years.

PROJECTED ACCRUAL: Approximately 175 patients will be accrued in the first 3 years of this study. ;

Study Design

Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00003097
Study type	Interventional
Source	National Cancer Institute (NCI)
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	April 1989

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT00423397` - Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer	Phase 1/Phase 2
Completed	`NCT00103246` - Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides	Phase 1
Active, not recruiting	`NCT00391300` - Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions	Phase 1
Completed	`NCT00066872` - Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer	Phase 3
Completed	`NCT00002963` - Photodynamic Therapy in Treating Patients With Skin Cancer	Phase 2
Completed	`NCT00021294` - Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis	Phase 2
Completed	`NCT00003611` - Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation	N/A
Terminated	`NCT00663910` - Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer	Phase 0
Recruiting	`NCT00295906` - Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control	N/A
Completed	`NCT00025012` - Isotretinoin in Preventing Skin Cancer	N/A
Completed	`NCT00021125` - Radiation Therapy in Treating Patients With Head and Neck Cancer	Phase 3
Completed	`NCT00601640` - Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin	Phase 2
Completed	`NCT00079300` - Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer	Phase 1
Completed	`NCT00017485` - Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer	Phase 1
Recruiting	`NCT00747903` - Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer	Phase 2
Terminated	`NCT00899132` - Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer	N/A
Completed	`NCT00099112` - Effect of Solar-Simulated Ultraviolet Radiation on Gene Expression in Unprotected and Sunscreen-Protected Skin of Healthy Adults With Fitzpatrick Skin Type II	N/A
Completed	`NCT00644384` - Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer	N/A
Completed	`NCT00023621` - Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome	Phase 2
Completed	`NCT00002975` - Photodynamic Therapy in Treating Patients With Skin Cancer	Phase 2